biosimilars and the oncology pcsp: value-based strategies to improve access and reduce cost
Published 5 years ago • 13 plays • Length 50:28Download video MP4
Download video MP3
Similar videos
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
38:15
biosimilars and biologics
-
4:53
the value and strategy for incorporating biosimilars into clinical practice
-
56:16
biosimilars in value based care oncology webinar
-
16:47
what is needed and what is the role of biosimilars?
-
3:33
biosimilars: manufacturing and inherent variation
-
23:20
biosimilars for ibd: when to start, switch, or stay away?
-
18:00
biosimilars part 1: history and biology
-
0:41
similarity of biosimilars and biologics
-
57:53
biosimilars: what you need to know
-
57:41
webinar: biologics & biosimilars
-
0:37
biosimilars can reduce cost and unlock access to safe and effective medicines
-
4:54
biosimilars in oncology: equivalency and cost
-
1:40
navigating the ibd landscape: the impact of biosimilars on cost, care, and the future of healthcare
-
2:56
biosimilars: costs and insurance coverage
-
6:43
biosimilars
-
1:48
dr. markman on the concept of biosimilars in oncology
-
6:00
quick guide to biosimilars
-
5:16
biosimilars: what oncologists need to know
-
0:53
dr. puhalla on the value of biosimilars in oncology
-
1:00:51
biosimilars explained: what patients need to know
-
5:58
the availability of multiple biosimilars for 1 biologic